Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
317.17
-3.49 (-1.09%)
Mar 9, 2026, 1:37 PM EDT - Market open

Alnylam Pharmaceuticals Revenue by Segment
Period Ending Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Amvuttra
2.31B 1.77B 1.35B 1.09B 970.41M 859.20M 749.30M 651.30M - - - - - - - - - - -
Amvuttra Growth
138.44% 106.44% 79.78% 66.62% 73.94% 90.43% 128.65% - - - - - - - - - - - -
Collaboration
553.37M 619.37M 325.03M 490.83M 510.15M 479.60M 849.70M 628.20M
Collaboration Growth
8.47% 29.14% -61.75% -21.87% -6.60% -11.25% 497.54% 332.05%
Givlaari
308.49M 286.34M 283.46M 264.71M 255.85M 250.50M 233.60M 229.40M
Givlaari Growth
20.58% 14.31% 21.35% 15.39% 16.72% 21.01% 17.62% 23.40%
Oxlumo
191.44M 185.36M 172.73M 166.46M 166.97M 156.10M 144.60M 128.20M - - - -
Oxlumo Growth
14.65% 18.75% 19.46% 29.85% 52.07% 54.71% 63.21% 61.66% - - - -
Royalty
174.02M 148.04M 125.23M 107.65M 91.79M 73.40M 59.90M 44.70M - - - - - -
Royalty Growth
89.59% 101.68% 109.07% 140.83% 126.08% 179.09% 213.61% 214.79% - - - - - -
Onpattro
172.79M 197.21M 208.43M 233.09M 252.80M 275.70M 307.00M 321.30M
Onpattro Growth
-31.65% -28.47% -32.11% -27.45% -28.71% -30.69% -33.43% -38.58%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.